Newsmakers

Biodexa (NASDAQ: BDRX)Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract – Now 12-Month Data

CARDIFF, UK July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is making good progress with eRapa™, […]

Newsmakers

Kazia Therapeutics (NASDAQ: KZIA) Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma

GBM AGILE trial data shows clinically meaningful improvement in a prespecified secondary analysis for overall survival in paxalisib-treated, newly diagnosed unmethylated patients with glioblastoma SYDNEY, July 10, 2024  — Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused […]

Newsmakers

Ocean Power Technologies (NASDAQ: OPTT) Partners with Unique Group for Autonomous Vehicle Services in the Middle East

Deploying commercially available solutions for Offshore Energy customers MONROE TOWNSHIP, N.J., July 02, 2024– Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, […]

Newsmakers

Loop Media (NASDAQ: LPTV) Announces Strategic Partnership with Outpatient Imaging Affiliates to Enhance Patient Experience in Imaging Centers Nationwide

GLENDALE, Calif., June 27, 2024—-Loop Media, Inc. (“Loop Media”) (NYSE American: LPTV), a leading multichannel streaming CTV platform that provides curated music videos, sports highlights, news, premium entertainment channels, and digital signage for businesses, and […]

Newsmakers

Senti Bio (NASDAQ: SNTI) Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy

$8M grant supports ongoing Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia SOUTH SAN FRANCISCO, Calif., July 01, 2024  — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti […]